Filing Flows › Comparisons › NEPH vs DRIO
Nephros vs DarioHealth: NEPH and DRIO compared
Nephros is the larger company: $5.6M of revenue in its latest quarter (Q3 2026) against $5.2M for DarioHealth (Q2 2026). Nephros is growing faster (+18% against -4% a year earlier). Nephros is more profitable, with an operating margin of 8.9% against -125.1%.
Where the money goes: NEPH and DRIO
Nephros (NEPH) · Q3 2026
Nephros, Q3 2026: revenue $5.6M (+18% year over year), operating margin 8.9%, net earnings $512K, operating cash flow −$150K. The chart follows the revenue to costs, profit and cash.
DarioHealth (DRIO) · Q2 2026
DarioHealth, Q2 2026: revenue $5.2M (-4% year over year), operating margin -125.1%, net loss $7.9M, operating cash flow −$6.1M. The chart follows the revenue to costs, profit and cash.
| Nephros (NEPH) | DarioHealth (DRIO) | |
|---|---|---|
| Latest quarter | Q3 2026 | Q2 2026 |
| Revenue | $5.6M | $5.2M |
| Revenue growth, Y/Y | +18% | -4% |
| Gross margin | 58.4% | — |
| Operating margin | 8.9% | -125.1% |
| Net earnings | $512K | −$7.9M |
| Net margin | 9.1% | -153.1% |
| Operating cash flow | −$150K | −$6.1M |
Where the revenue comes from
Nephros
- Product: $5.4M (97%)
- Service Royalty and Other Revenues: $191K (3%)
DarioHealth
- Hardware and Consumable Products: $2.6M (50%)
- Services: $2.6M (50%)
Questions
Which is bigger, Nephros or DarioHealth?
Nephros is the larger company: $5.6M of revenue in its latest quarter (Q3 2026) against $5.2M for DarioHealth (Q2 2026).
Is Nephros or DarioHealth growing faster?
Nephros is growing faster (+18% against -4% a year earlier).
Which is more profitable, Nephros or DarioHealth?
Nephros is more profitable, with an operating margin of 8.9% against -125.1%.
More: Nephros earnings · how Nephros makes money · DarioHealth earnings · how DarioHealth makes money
From the companies' latest 10-Q, 10-K or earnings release (10-Q filed Nov 5, 2026; 10-Q filed Aug 11, 2026). Fiscal quarters can end on different dates. Not investment advice.